CancerVax Adds Phillip Schneider to Board of Directors.Business Editors/Health/Medical Writers BIOWIRE2K CARLSBAD, Calif.--(BUSINESS WIRE)--Sept. 24, 2003 CancerVax Corporation announced today that Phillip M. Schneider, M.B.A., C.P.A., has joined the Company's Board of Directors and will serve as Audit Committee Chairman. Schneider brings 22 years of experience in the pharmaceutical industry to the Board of CancerVax, including 15 years of financial management experience at IDEC IDEC Instituto Brasileiro de Defesa do Consumidor (Portugese: Brazilian Consumer Protection Agency) IDEC Information Design & End-User Computing IDEC Interior Design Educators Council, Inc. Pharmaceuticals Corporation where he recently retired as Senior Vice President and Chief Financial Officer. "Phillip is an important addition to the CancerVax Board of Directors, and his expertise in public company finance and corporate governance will be very valuable," said David F. Hale, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CancerVax. Schneider currently serves as a member of the Board of Directors and Chairman of the Audit Committee for Gen-Probe Inc. Previously, during his career with IDEC, he led a team of 70 people who had responsibility for SEC reporting, accounting and treasury, among other activities. Schneider was the lead finance member for IDEC's initial public offering and helped raise over $1 billion in financing through private equity, public equity, partnership financing and convertible debt. Prior to joining IDEC, Schneider served in a number of corporate finance and financial reporting capacities with Syntex Pharmaceuticals Corporation and was previously with KPMG KPMG Klynveld Peat Marwick Goerdeler (accounting firm) KPMG Kaiser Permanente Medical Group KPMG Keiner Prüft Mehr Genau (German) KPMG Kommen Prüfen Meckern Gehen , LLP LLP - Lower Layer Protocol . Schneider received his M.B.A. from the University of Southern California The U.S. News & World Report ranked USC 27th among all universities in the United States in its 2008 ranking of "America's Best Colleges", also designating it as one of the "most selective universities" for admitting 8,634 of the almost 34,000 who applied for freshman admission and his B.S. in Biochemistry from the University of California, Davis The University of California, Davis, commonly known as UC Davis, is one of the ten campuses of the University of California, and was established as the University Farm in 1905. . CancerVax(R) is a registered trademark of CancerVax Corporation. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion